1Yoon JC,Chickering TW,Rosen ED,et al.Peroxisome proliferators-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation[J].Mol Cell Biol,2000,20(14):5343-5349
2Fukui Y,MaSui S,Osada S,et al.A new thiazolidinedione,NC2100,which is a weak PPAR-gamma activator,exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice[J].Diabetes,2000,49 (5):759-767
4Edwards G,Lee CE,Maher LJ,et al.The effects of pioglitazone,metformin and gliclazide as monotherapy or in combinationon3 -hour OGTT investigations[J].Diabetes,2003,52 (Suppl 1):A141-142
5Parulkar AA,Pendergrass ML,Granda-Ayala R,et al.Nonhypoglycemic effects of thiazolidinediones[J].Ann Intern Med,2001,134(1):61-67
6Rely CM,Oates JC,Cook JA,et al.Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists[J].J Immunol,2000,164(3):1498-1504
7Noriko Satoh,Yoshihiro Ogawa,Takeshi Usui,et al.Antiatherogenic effect of piogllitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect[J].Diabetes Care,2003,26(9):2493-2499
二级参考文献12
1Shi maya A, Kurosaki E, Nakano R, et al. The novel hypoglycemic agent YM440 normalizes hyperglyce mia without changing body fat weight in diabetic db/db mice. Metabolism 2000; 49 ( 3 ):411.
2De Vos P, Lefebvre AM, Mller SG, et al. Thiazolidine diones repress ob gene expression in rodents via activation of peroxisome proliferator - activated receptor γ, J Clin Invest 1996; 98:1004.
3Parulkar AA, Pendergrass ML, Granda - Ayala R, et al. Nonhypoglyce mic effects of thiazolidinediones, Ann Intern Med 2001;134(1) :61.
4Isshiki K, Haneda M, Koya D, et al. Thiazolidine dione compounds ameliorate glomerular dysfunction independent of their insulin -sensi- tizing action in diabetic rats. Diabetes 2000 ;49(6):1022.
5Asano M, Nakajima T, I wase wa K, et al. Troglitazone and pioglitazone attenuate agonist- dependent Ca2+ mobilization and cell prolifera - tion in vascular smooth muscle cells. Br J Pharmacol 1999;128(3) :673.
6Reilly CM, Oates JC, Cood JA, et al. Inhibition of mesangial cell nitric oxide in MRL/1pr mice by prostaglandin J2 and prolife rator activation receptor - gamma agonists. J Immunol 2000; 164 ( 3 ):1498.
7Park BH, Breyer B, He TC. Peroxisome proliferator- activated receptors: roles in tumorigenesis and che moprevention in human cancer, Curr Opin Oncol 2001,13(1) :78.
8Brown MN. The thiazolidinediones or"glitasones" a treatment option for type 2 diabetes mellitus. Med Health R1 2000;83(4): 118.
9Yoon JC, Chickering TW, Rosen ED, et al.Reroxisome prolife rator- activated receptor gamma target gene encoding a novel angiopoietin - related protein associated with adipose differentiation. Mol Cell Biol 2000;20(14):5343.
10Hayakawa T, Shiraki T, Morimoto T, et al. Pioglitazone improves insulin signa ling defects in skeletal from Wistar fatty(fa/fa)rats. Biochem Biophys Res Commun 1996;223:439.
